|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stupp R, Hegi ME, Mason WP, van den Bent
MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B,
Belanger K, et al European Organisation for Research and Treatment
of Cancer Brain Tumour and Radiation Oncology Groups; National
Cancer Institute of Canada Clinical Trials Group: Effects of
radiotherapy with concomitant and adjuvant temozolomide versus
radiotherapy alone on survival in glioblastoma in a randomised
phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet
Oncol. 10:459–466. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kirkpatrick JP, Laack NN, Shih HA and
Gondi V: Management of GBM: A problem of local recurrence. J
Neurooncol. 134:487–493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fidoamore A, Cristiano L, Antonosante A,
d'Angelo M, Di Giacomo E, Astarita C, Giordano A, Ippoliti R,
Benedetti E and Cimini A: Glioblastoma stem cells microenvironment:
The paracrine roles of the niche in drug and radioresistance. Stem
Cells Int. 2016:68091052016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Liu W, Chao T, Zhang Y, Yan X,
Gong Y, Qiang B, Yuan J, Sun M and Peng X: MicroRNA-21
down-regulates the expression of tumor suppressor PDCD4 in human
glioblastoma cell T98G. Cancer Lett. 272:197–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu J, Sun T, Wang H, Chen Z, Wang S, Yuan
L, Liu T, Li HR, Wang P, Feng Y, et al: miR-215 Is induced
post-transcriptionally via HIF-Drosha complex and mediates
glioma-initiating cell adaptation to hypoxia by targeting KDM1B.
Cancer Cell. 29:49–60. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi Y, Chen C, Zhang X, Liu Q, Xu JL,
Zhang HR, Yao XH, Jiang T, He ZC, Ren Y, et al: Primate-specific
miR-663 functions as a tumor suppressor by targeting PIK3CD and
predicts the prognosis of human glioblastoma. Clin Cancer Res.
20:1803–1813. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hong Y, Liang H, Uzair-Ur-Rehman, Wang Y,
Zhang W, Zhou Y, Chen S, Yu M, Cui S, Liu M, et al: miR-96 promotes
cell proliferation, migration and invasion by targeting PTPN9 in
breast cancer. Sci Rep. 6:374212016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu L, Zhong J, Guo B, Zhu Q, Liang H, Wen
N, Yun W and Zhang L: miR-96 promotes the growth of prostate
carcinoma cells by suppressing MTSS1. Tumour Biol. 37:12023–12032.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang TH, Yeh CT, Ho JY, Ng KF and Chen TC:
OncomiR miR-96 and miR-182 promote cell proliferation and invasion
through targeting ephrinA5 in hepatocellular carcinoma. Mol
Carcinog. 55:366–375. 2016. View
Article : Google Scholar
|
|
13
|
Ma Y, Yang HZ, Dong BJ, Zou HB, Zhou Y,
Kong XM and Huang YR: Biphasic regulation of autophagy by miR-96 in
prostate cancer cells under hypoxia. Oncotarget. 5:9169–9182. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanaka M, Suzuki HI, Shibahara J, Kunita
A, Isagawa T, Yoshimi A, Kurokawa M, Miyazono K, Aburatani H,
Ishikawa S, et al: EVI1 oncogene promotes KRAS pathway through
suppression of microRNA-96 in pancreatic carcinogenesis. Oncogene.
33:2454–2463. 2014. View Article : Google Scholar
|
|
16
|
Ress AL, Stiegelbauer V, Winter E,
Schwarzenbacher D, Kiesslich T, Lax S, Jahn S, Deutsch A,
Bauernhofer T, Ling H, et al: miR-96–5p influences cellular growth
and is associated with poor survival in colorectal cancer patients.
Mol Carcinog. 54:1442–1450. 2015. View
Article : Google Scholar
|
|
17
|
Leung WK, He M, Chan AW, Law PT and Wong
N: Wnt/β-Catenin activates miR-183/96/182 expression in
hepatocellular carcinoma that promotes cell invasion. Cancer Lett.
362:97–105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu L, Pu X, Wang Q, Cao J, Xu F, Xu LI and
Li K: miR-96 induces cisplatin chemoresistance in non-small cell
lung cancer cells by downregulating SAMD9. Oncol Lett. 11:945–952.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xia H, Chen S, Chen K, Huang H and Ma H:
miR-96 promotes proliferation and chemo- or radioresistance by
down-regulating RECK in esophageal cancer. Biomed Pharmacother.
68:951–958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao J, Liu R, Shi YJ, Yin LH and Pu YP:
Exosome-shuttling microRNA-21 promotes cell migration and
invasion-targeting PDCD4 in esophageal cancer. Int J Oncol.
48:2567–2579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Gee H, Rose B, Lee CS, Clark J,
Elliott M, Gamble JR, Cairns MJ, Harris A, Khoury S, et al:
Regulation of the tumour suppressor PDCD4 by miR-499 and miR-21 in
oropharyngeal cancers. BMC Cancer. 16:862016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hwang SK, Baker AR, Young MR and Colburn
NH: Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription
in human glioblastoma cells by direct interaction with p65.
Carcinogenesis. 35:1469–1480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang L, Zhao M, Guo C, Wang G, Zhu F, Wang
J, Wang X, Wang Q, Zhao W, Shi Y, et al: PDCD4 deficiency
aggravated colitis and colitis-associated colorectal cancer via
promoting IL-6/STAT3 pathway in mice. Inflamm Bowel Dis.
22:1107–1118. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhen Y, Li D, Li W, Yao W, Wu A, Huang J,
Gu H, Huang Y, Wang Y, Wu J, et al: Reduced PDCD4 expression
promotes sell growth through PI3K/Akt signaling in non-small cell
lung cancer. Oncol Res. 23:61–68. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen Z, Yuan YC, Wang Y, Liu Z, Chan HJ
and Chen S: Down-regulation of programmed cell death 4 (PDCD4) is
associated with aromatase inhibitor resistance and a poor prognosis
in estrogen receptor-positive breast cancer. Breast Cancer Res
Treat. 152:29–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Supiot S, Gouraud W, Campion L, Jezéquel
P, Buecher B, Charrier J, Heymann MF, Mahé MA, Rio E and Chérel M:
Early dynamic transcriptomic changes during preoperative
radiotherapy in patients with rectal cancer: A feasibility study.
World J Gastroenterol. 19:3249–3254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bredel M, Scholtens DM, Harsh GR, Bredel
C, Chandler JP, Renfrow JJ, Yadav AK, Vogel H, Scheck AC,
Tibshirani R, et al: A network model of a cooperative genetic
landscape in brain tumors. JAMA. 302:261–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gao F, Wang X, Zhu F, Wang Q, Zhang X, Guo
C, Zhou C, Ma C, Sun W, Zhang Y, et al: PDCD4 gene silencing in
gliomas is associated with 5′CpG island methylation and
unfavourable prognosis. J Cell Mol Med. 13:4257–4267. 2009.
View Article : Google Scholar
|
|
29
|
Xiao J, Pan Y, Li XH, Yang XY, Feng YL,
Tan HH, Jiang L, Feng J and Yu XY: Cardiac progenitor cell-derived
exosomes prevent cardiomyocytes apoptosis through exosomal miR-21
by targeting PDCD4. Cell Death Dis. 7:e22772016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jiang LP, He CY and Zhu ZT: Role of
microRNA-21 in radiosensitivity in non-small cell lung cancer cells
by targeting PDCD4 gene. Oncotarget. 8:23675–23689. 2017.PubMed/NCBI
|
|
31
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:54re32016. View Article : Google Scholar
|
|
32
|
Lee DH, Ryu HW, Won HR and Kwon SH:
Advances in epigenetic glioblastoma therapy. Oncotarget.
8:18577–18589. 2017.PubMed/NCBI
|
|
33
|
Shen Y, Wang Y, Sheng K, Fei X, Guo Q,
Larner J, Kong X, Qiu Y and Mi J: Serine/threonine protein
phosphatase 6 modulates the radiation sensitivity of glioblastoma.
Cell Death Dis. 2:e2412011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jalbert LE, Elkhaled A, Phillips JJ, Neill
E, Williams A, Crane JC, Olson MP, Molinaro AM, Berger MS,
Kurhanewicz J, et al: Metabolic profiling of IDH mutation and
malignant progression in infiltrating glioma. Sci Rep. 7:447922017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang J, Su HK, Zhao HF, Chen ZP and To SS:
Progress in the application of molecular biomarkers in gliomas.
Biochem Biophys Res Commun. 465:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Binabaj MM, Bahrami A, ShahidSales S,
Joodi M, Joudi Mashhad M, Hassanian SM, Anvari K and Avan A: The
prognostic value of MGMT promoter methylation in glioblastoma: A
meta-analysis of clinical trials. J Cell Physiol. 233:378–386.
2018. View Article : Google Scholar
|
|
37
|
Figueroa JM, Skog J, Akers J, Li H,
Komotar R, Jensen R, Ringel F, Yang I, Kalkanis S, Thompson R, et
al: Detection of wild-type EGFR amplification and EGFRvIII mutation
in CSF-derived extracellular vesicles of glioblastoma patients.
Neuro Oncol. 19:1494–1502. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Guo Q, Guo P, Mao Q, Lan J, Lin Y, Jiang J
and Qiu Y: ID1 affects the efficacy of radiotherapy in glioblastoma
through inhibition of DNA repair pathways. Med Oncol. 30:3252013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Costa PM, Cardoso AL, Nóbrega C, Pereira
de Almeida LF, Bruce JN, Canoll P and Pedroso de Lima MC:
MicroRNA-21 silencing enhances the cytotoxic effect of the
antiangiogenic drug sunitinib in glioblastoma. Hum Mol Genet.
22:904–918. 2013. View Article : Google Scholar :
|
|
41
|
Cheng Y, Xiang G, Meng Y and Dong R:
MiRNA-183-5p promotes cell proliferation and inhibits apoptosis in
human breast cancer by targeting the PDCD4. Reprod Biol.
16:225–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
